The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cyclooxygenase inhibitor use during checkpoint blockade immunotherapy and effect on time to progression for metastatic melanoma patients.
 
Shang-Jui Wang
No Relationships to Disclose
 
Karishma Khullar
No Relationships to Disclose
 
Nikhil Yegya-Raman
No Relationships to Disclose
 
Sinae Kim
No Relationships to Disclose
 
Ann W. Silk
Consulting or Advisory Role - Merck
Research Funding - Amgen (Inst); Biohaven Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Prometheus (Inst); Viralytics (Inst)
 
Jyoti Malhotra
Consulting or Advisory Role - AstraZeneca; Pfizer
Research Funding - BeyondSpring Pharmaceuticals (Inst); Biohaven Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst)
 
Michael A. Gentile
Research Funding - Merck
 
Janice M. Mehnert
Honoraria - EMD Serono; Pfizer/EMD Serono
Consulting or Advisory Role - Amgen; Array BioPharma; Array BioPharma; Boehringer Ingelheim
Research Funding - Amgen (Inst); AstraZeneca (Inst); Immunocore (Inst); Incyte (Inst); macrogenics (Inst); macrogenics (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); polynoma (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - EMD Serono; Merck Sharp & Dohme
Other Relationship - Amgen; Array BioPharma; Boehringer Ingelheim; EMD Serono; Merck; Merck
 
Salma K. Jabbour
Consulting or Advisory Role - Merck Sharp & Dohme
Research Funding - Merck Sharp & Dohme (Inst); Nestle health science (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme